- Bunge Global SA reported third quarter 2025 earnings with sales of US$22.16 billion and net income of US$166 million, exceeding analyst consensus for earnings per share.
- Despite higher sales, quarterly net income decreased compared to the prior year as margins tightened, though nine-month net income and earnings per share improved year over year.
- We’ll assess how Bunge Global’s better-than-expected earnings per share shapes the company’s outlook for margin growth and future catalysts.
AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
Bunge Global Investment Narrative Recap
Bunge Global appeals to investors who believe in the long-term growth of global agribusiness through operational scale and integration, particularly following its merger with Viterra. While the latest quarterly earnings exceeded consensus EPS expectations, tightening margins and softer performance in refined and specialty oils mean that the most important short-term catalyst, successful margin improvement from integration and cost synergies, remains only partially addressed, and execution risk tied to merger integration is still the biggest risk; this quarter’s report does not materially change that equation for now.
Among Bunge Global’s recent announcements, the completion of the Viterra merger in July directly connects to this quarter’s financials, as it marks a pivotal step in expanding the company’s scale and unlocking promised synergies. Management’s ability to manage costs, extract value, and integrate operations following this merger will continue to drive sentiment, especially as investors consider whether the merger’s benefits can successfully outpace ongoing headwinds in certain segments.
Yet, in contrast to integration optimism, investors should be aware that if synergy realization lags or costs are higher than anticipated...
Read the full narrative on Bunge Global (it's free!)
Bunge Global's narrative projects $56.6 billion revenue and $1.1 billion earnings by 2028. This requires 3.3% yearly revenue growth and no change in earnings from the current $1.1 billion.
Uncover how Bunge Global's forecasts yield a $99.67 fair value, a 4% upside to its current price.
Exploring Other Perspectives
Five fair value estimates from the Simply Wall St Community range from US$79.30 to US$385.06, capturing diverse views on Bunge Global’s worth. While many see merger-driven margin growth as a catalyst, your own outlook depends on how you weigh integration risks and evolving global demand.
Explore 5 other fair value estimates on Bunge Global - why the stock might be worth 17% less than the current price!
Build Your Own Bunge Global Narrative
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
- A great starting point for your Bunge Global research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
- Our free Bunge Global research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Bunge Global's overall financial health at a glance.
Interested In Other Possibilities?
These stocks are moving-our analysis flagged them today. Act fast before the price catches up:
- The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 25 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
- Explore 27 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
- We've found 20 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Bunge Global might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com